Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for XRAY

Stock NameDentsply Sirona Inc
TickerXRAY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS24906P1093
LEI9NHEHR1SOZCYXDO8HO28

Show aggregate XRAY holdings

News associated with XRAY

Head-To-Head Survey: DENTSPLY SIRONA (NASDAQ:XRAY) and Spotlight Innovation (OTCMKTS:STLT)
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and Spotlight Innovation (OTCMKTS:STLT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares DENTSPLY SIRONA and Spotlight […] - 2025-09-04 05:09:06
UBS Group Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $24.00
DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its target price reduced by UBS Group from $25.00 to $24.00 in a research report released on Friday morning,Benzinga reports. UBS Group currently has a buy rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a […] - 2025-08-11 02:58:47
DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to “Hold” Rating by Wall Street Zen
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Other equities analysts have also recently issued research reports about the stock. Barrington Research cut their target price on shares of DENTSPLY SIRONA from […] - 2025-08-11 02:58:46
Stifel Nicolaus Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $17.00
DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its target price lowered by Stifel Nicolaus from $19.00 to $17.00 in a research note issued to investors on Friday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the medical instruments supplier’s stock. XRAY has been the subject of a number of other research reports. Piper […] - 2025-08-11 02:58:46
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of “Hold” by Brokerages
DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target […] - 2025-07-29 02:30:59
Peek Under The Hood: ONEV Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-25 08:58:55
Envestnet Asset Management Inc. Purchases 40,936 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Envestnet Asset Management Inc. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 494,737 shares of the medical instruments supplier’s stock after buying an additional 40,936 […] - 2025-07-23 04:46:55
Needham & Company LLC Reaffirms “Hold” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued on Monday,Benzinga reports. Several other equities analysts also recently issued reports on XRAY. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating […] - 2025-07-23 03:58:51
Cwm LLC Buys 52,727 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Cwm LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 124.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 95,087 shares of the medical instruments supplier’s stock after purchasing an additional 52,727 shares during the quarter. Cwm LLC’s holdings in DENTSPLY SIRONA were worth $1,421,000 as of its most […] - 2025-07-21 06:23:36
Bank of New York Mellon Corp Has $33.80 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Bank of New York Mellon Corp reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 5.9% in the 1st quarter, Holdings Channel reports. The firm owned 2,262,213 shares of the medical instruments supplier’s stock after selling 140,897 shares during the period. Bank of New York Mellon Corp’s holdings in DENTSPLY SIRONA were […] - 2025-07-16 05:16:50
DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Buy at Wall Street Zen
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Sunday. Several other brokerages have also recently issued reports on XRAY. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $27.00 to […] - 2025-07-15 03:07:00
YieldBoost DENTSPLY SIRONA To 21.8% Using Options
Shareholders of DENTSPLY SIRONA Inc (Symbol: XRAY) looking to boost their income beyond the stock's 3.9% annualized dividend yield can sell the October covered call at the $17.50 strike and collect the premium based on the 80 cents bid, which annualizes to an additional 17.9% ra - 2025-07-09 12:39:32
Analyzing DENTSPLY SIRONA (NASDAQ:XRAY) and Green Cures & Botanical Distribution (OTCMKTS:GRCU)
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and Green Cures & Botanical Distribution (OTCMKTS:GRCU – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Profitability This table compares DENTSPLY […] - 2025-07-09 05:51:36
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Position Lowered by Amalgamated Bank
Amalgamated Bank lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 2.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 92,303 shares of the medical instruments supplier’s stock after selling 2,285 shares during the period. Amalgamated Bank’s holdings in DENTSPLY SIRONA were worth $1,379,000 at the end of […] - 2025-07-08 05:30:56
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 39.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,903 shares of the medical instruments supplier’s stock after acquiring an […] - 2025-07-03 04:26:52
Envestnet Portfolio Solutions Inc. Sells 4,606 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Envestnet Portfolio Solutions Inc. cut its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 29.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,295 shares of the medical instruments supplier’s stock after selling 4,606 shares during the period. […] - 2025-07-01 04:46:53
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 57.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 12,554 shares of the medical instruments supplier’s stock after purchasing an additional 4,595 shares during […] - 2025-06-25 04:35:09
Rhumbline Advisers Trims Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Rhumbline Advisers cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 2.3% during the first quarter, HoldingsChannel.com reports. The fund owned 555,008 shares of the medical instruments supplier’s stock after selling 13,241 shares during the quarter. Rhumbline Advisers’ holdings in DENTSPLY SIRONA were worth $8,292,000 at the end of the […] - 2025-06-11 05:46:47
Merit Financial Group LLC Purchases Shares of 36,649 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Merit Financial Group LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 36,649 shares of the medical instruments supplier’s stock, valued at approximately $548,000. Several other hedge funds have also […] - 2025-06-10 04:45:03
Public Employees Retirement System of Ohio Has $1.32 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Public Employees Retirement System of Ohio reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,415 shares of the medical instruments supplier’s stock after selling 3,974 shares during […] - 2025-06-03 05:25:01
Analysts Expect 10% Gains Ahead For The Holdings of DIVB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-22 07:58:23
Janus Henderson Group PLC Sells 6,291,054 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Janus Henderson Group PLC lowered its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 98.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,713 shares of the medical instruments supplier’s stock after selling 6,291,054 […] - 2025-05-22 06:49:00
Nomura Holdings Inc. Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Nomura Holdings Inc. acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 26,376 shares of the medical instruments supplier’s stock, valued at approximately $501,000. Other institutional investors […] - 2025-05-22 06:48:57
Focus Partners Wealth Acquires Shares of 15,826 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Focus Partners Wealth acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 15,826 shares of the medical instruments supplier’s stock, valued at approximately $300,000. A number of other […] - 2025-05-22 05:20:52
Captrust Financial Advisors Acquires 6,609 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Captrust Financial Advisors boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 39.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,548 shares of the medical instruments supplier’s stock after buying an additional 6,609 […] - 2025-05-20 05:22:52
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Stifel Financial Corp
Stifel Financial Corp reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 37.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,859 shares of the medical instruments supplier’s stock after selling 11,934 shares during […] - 2025-05-14 04:56:50
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Expected to Rise, Barrington Research Analyst Says
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its target price raised by investment analysts at Barrington Research from $20.00 to $21.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective suggests a potential upside of 26.51% from the […] - 2025-05-14 03:14:50
DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com
StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other brokerages also recently weighed in on XRAY. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price […] - 2025-05-12 02:22:42
Strong Insider Buying Reported in BTAL Holdings
A look at the weighted underlying holdings of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL) shows an impressive 111.1% of holdings on a weighted basis have experienced insider buying within the past six months. Match Group Inc (Symbol: MTCH), which makes up 34.16% of the A - 2025-05-08 10:56:10
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year Low Following Analyst Downgrade
DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from $20.00 to $16.00. Piper Sandler currently has a neutral rating on the stock. DENTSPLY SIRONA traded as low as $13.38 and last traded at […] - 2025-05-01 04:47:02

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc XRAY holdings

DateNumber of XRAY Shares HeldBase Market Value of XRAY SharesLocal Market Value of XRAY SharesChange in XRAY Shares HeldChange in XRAY Base ValueCurrent Price per XRAY Share HeldPrevious Price per XRAY Share Held
2025-09-26 (Friday)66,988USD 837,350USD 837,350
2025-09-25 (Thursday)66,988USD 828,642XRAY holding decreased by -33494USD 828,6420USD -33,494 USD 12.37 USD 12.87
2025-09-24 (Wednesday)66,988USD 862,136USD 862,136
2025-09-17 (Wednesday)66,554USD 893,820XRAY holding decreased by -12645USD 893,8200USD -12,645 USD 13.43 USD 13.62
2025-09-16 (Tuesday)66,554USD 906,465USD 906,465
2025-09-12 (Friday)66,120USD 894,604USD 894,604
2025-09-11 (Thursday)66,120USD 921,713USD 921,713
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of XRAY by Blackrock for IE00B3VWM098

Show aggregate share trades of XRAY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-217 13.900* 17.02 Profit of 3,693 on sale
2025-07-31BUY651 14.310* 17.05
2025-06-30SELL-434 15.880* 17.16 Profit of 7,449 on sale
2025-06-25SELL-217 16.000* 17.19 Profit of 3,730 on sale
2025-06-20SELL-434 15.360* 17.22 Profit of 7,475 on sale
2025-05-23BUY217 15.470* 17.44
2025-05-19SELL-217 16.630* 17.49 Profit of 3,794 on sale
2025-05-15SELL-651 16.500* 17.50 Profit of 11,393 on sale
2025-05-12SELL-217 16.750* 17.52 Profit of 3,803 on sale
2025-05-09SELL-217 15.810* 17.54 Profit of 3,806 on sale
2025-04-30SELL-217 13.900* 17.77 Profit of 3,857 on sale
2025-04-24SELL-434 13.710* 17.93 Profit of 7,783 on sale
2025-04-17SELL-217 12.830* 18.20 Profit of 3,949 on sale
2025-04-15SELL-651 12.550* 18.32 Profit of 11,927 on sale
2025-04-14SELL-651 13.080* 18.38 Profit of 11,964 on sale
2025-04-09SELL-872 13.660* 18.56 Profit of 16,185 on sale
2025-04-07SELL-1,526 13.240* 18.69 Profit of 28,523 on sale
2025-04-04SELL-2,180 13.580* 18.75 Profit of 40,878 on sale
2025-03-31BUY218 14.940* 18.89
2025-03-19SELL-436 15.660* 19.26 Profit of 8,396 on sale
2025-03-17BUY6,357 15.590* 19.36
2025-03-14SELL-1,188 15.560* 19.41 Profit of 23,060 on sale
2025-03-13SELL-398 15.000* 19.47 Profit of 7,750 on sale
2025-03-12SELL-6,766 15.330* 19.53 Profit of 132,164 on sale
2025-03-07SELL-398 16.320* 19.69 Profit of 7,837 on sale
2025-03-06SELL-597 16.260* 19.74 Profit of 11,786 on sale
2025-03-03SELL-199 15.990* 19.93 Profit of 3,966 on sale
2025-02-28BUY34,290 16.550* 19.98
2025-02-26SELL-105 18.810* 20.05 Profit of 2,105 on sale
2025-02-25SELL-315 18.820* 20.07 Profit of 6,323 on sale
2025-02-18BUY525 18.840* 20.18
2025-02-13BUY105 18.770* 20.28
2025-02-12BUY105 18.370* 20.32
2025-02-11BUY315 18.280* 20.37
2025-02-06BUY945 19.210* 20.47
2025-01-27BUY105 19.610* 20.66
2024-12-30BUY525 18.650* 20.85
2024-12-06BUY420 19.080* 20.99
2024-12-05BUY105 19.310* 21.05
2024-12-04BUY525 19.460* 21.11
2024-11-29BUY525 19.650* 21.29
2024-11-27BUY420 19.640* 21.43
2024-11-26BUY105 19.190* 21.53
2024-11-25SELL-7,721 19.520* 21.63 Profit of 167,002 on sale
2024-11-21BUY640 18.640* 21.94
2024-11-20BUY384 18.520* 22.13
2024-11-18BUY1,536 18.460* 22.56
2024-11-12BUY1,024 17.770* 22.88
2024-11-08BUY640 17.860* 23.24
2024-11-07BUY1,905 17.260* 23.70
2024-11-06BUY254 23.980* 23.67
2024-10-31BUY127 23.170* 23.84
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of XRAY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19395,70201,217,72732.5%
2025-09-18434,61001,179,67636.8%
2025-09-17324,83301,009,86332.2%
2025-09-16315,1460858,74436.7%
2025-09-15761,10801,499,95550.7%
2025-09-12579,42101,125,88251.5%
2025-09-11286,1470533,07853.7%
2025-09-10396,7877834,82247.5%
2025-09-091,045,73701,340,66678.0%
2025-09-08375,60144725,53751.8%
2025-09-05275,7840686,02240.2%
2025-09-04867,3386,8891,328,32365.3%
2025-09-03288,26622,730903,07131.9%
2025-09-02333,3000818,65740.7%
2025-08-29200,0212,050574,28134.8%
2025-08-28424,7742,9001,022,58941.5%
2025-08-27335,09301,625,65920.6%
2025-08-26305,9750708,75843.2%
2025-08-25323,4270726,10444.5%
2025-08-22322,919382710,39145.5%
2025-08-21372,4270699,50253.2%
2025-08-20582,43201,006,79957.8%
2025-08-19288,7930764,73537.8%
2025-08-18340,3430841,71640.4%
2025-08-15355,5840830,75242.8%
2025-08-14707,08101,229,03557.5%
2025-08-13695,55001,699,21440.9%
2025-08-12389,372251,195,85932.6%
2025-08-11976,08728,8601,881,90151.9%
2025-08-08905,3713202,794,02632.4%
2025-08-071,653,4004273,105,35553.2%
2025-08-06740,34702,419,78230.6%
2025-08-05557,371781,551,52535.9%
2025-08-04227,27301,105,33220.6%
2025-08-01328,48502,162,27415.2%
2025-07-31430,13181,954,99722.0%
2025-07-30386,46820987,22539.1%
2025-07-29337,02819702,47448.0%
2025-07-28530,918500975,94854.4%
2025-07-25336,787661,165,35528.9%
2025-07-24325,0520743,49643.7%
2025-07-23563,47303,506,92216.1%
2025-07-22835,7781102,272,47936.8%
2025-07-21795,42412,992,84326.6%
2025-07-18227,6090535,53542.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.